A Study to Evaluate the Safety and Efficacy of Prograf/FK778 and Prograf/MMF in de Novo Kidney Transplant Recipients

Stopped early · Phase 2

Conditions studied: Kidney Transplantation

In brief

A study to evaluate the safety and efficacy of Prograf/FK778 in de novo kidney transplant patients

Key facts

Study ID

NCT00282230

Run by

Astellas Pharma Inc

People needed

150

Starts

2003-11-01

Expected to finish

2005-10-01

Last updated by the study team

2012-06-07

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patient is a recipient of a primary or retransplanted cadaveric or non-HLA-identical living donor kidney.
• Patient must receive first oral dose of randomized study drug within 48 hours of transplant procedure.

You may not qualify if…

• Patient has received or is receiving an organ transplant other than kidney
• Patient has received a kidney transplant from a cadaveric donor >= 60 years of age.

Where it is running

• Study site — Birmingham, Alabama, United States
• Study site — Los Angeles, California, United States
• Study site — San Diego, California, United States
• Study site — Denver, Colorado, United States
• Study site — Washington D.C., District of Columbia, United States
• Study site — Jacksonville, Florida, United States
• Study site — Miami, Florida, United States
• Study site — Chicago, Illinois, United States
• Study site — Indianapolis, Indiana, United States
• Study site — Wichita, Kansas, United States
• Study site — New Orleans, Louisiana, United States
• Study site — Detroit, Michigan, United States
• Study site — New Brunswick, New Jersey, United States
• Study site — New York, New York, United States
• Study site — New York, New York, United States
• Study site — Durham, North Carolina, United States
• Study site — Cincinnati, Ohio, United States
• Study site — Harrisburg, Pennsylvania, United States
• Study site — Philadelphia, Pennsylvania, United States
• Study site — Memphis, Tennessee, United States
• Study site — Salt Lake City, Utah, United States
• Study site — Madison, Wisconsin, United States
• Study site — Milwaukee, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.